Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Largo del Pozzo 71, 41124, Modena, Italy.
Updates Surg. 2022 Apr;74(2):773-777. doi: 10.1007/s13304-021-01209-x. Epub 2021 Nov 30.
Perihilar cholangiocarcinoma (pCCA) is one of the most complex challenges for hepatobiliary surgeons. Poor results and high incidence of morbidity after Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) for pCCA discouraged this indication. It has been proposed that minimally invasive approach for ALPPS first stage, as well as combination of surgical liver partition and radiologic portal vein embolization (PVE), may improve outcomes reducing interstage morbidity. We report a case of right trisectionectomy with enbloc caudatectomy ALPPS scheduled for pCCA with robotic approach at stage-1, the full video is provided as supplementary material. Due to intraoperative presence of portal vein tumor infiltration during hilar dissection (no evidence in the pre-operative work-up), a radiologic right PVE was performed after stage-1 instead of portal vein ligation, followed by portal vein resection and biductal hepatico-jejunostomy at stage-2 with open approach. The patient was a 74-year-old female diagnosed with 3-cm mass-forming pCCA. The total clean liver volume was 1231 cc, with future liver remnant (FLR) volume of 25.1% (segments II and III). She was discharged in the interstage interval on postoperative day (POD) 4; CT scan on POD 12 showed that FLR increased up to 33% (369 cc) (Fig. 1). ALPPS was completed on POD 17, the postoperative course was uneventful, and the patient was discharged in good general condition on POD 19 after stage-2. Besides the already demonstrated advantages in terms of reduced interstage morbidity, robotic ALPPS represents a promising strategy to expand surgical indication in patients with pCCA. The combination of liver partition and PVE may increase the opportunities to perform radical resections in selected patients with pCCA and portal vein infiltration.
肝门部胆管癌(pCCA)是肝胆外科医生面临的最复杂挑战之一。由于 Associating Liver Partition and Portal vein ligation for Staged hepatectomy(ALPPS)治疗 pCCA 的效果不佳和发病率高,该手术不再适用于 pCCA。目前,有人提出 ALPPS 一期手术采用微创方法,联合手术性肝段分隔和放射学门静脉栓塞术(PVE),可能会降低手术间发病率,改善预后。我们报告了一例机器人辅助右三叶切除术联合尾状叶整块切除术的 ALPPS 治疗 pCCA 病例,一期手术采用机器人方法,完整视频作为补充材料提供。由于在肝门部解剖过程中发现门静脉肿瘤浸润(术前检查未见),因此在一期手术后进行了右 PVE,而不是门静脉结扎,然后在二期手术中采用开放方法进行门静脉切除和双胆管肝肠吻合术。患者为 74 岁女性,诊断为 3cm 肿块形成的 pCCA。总肝切除量为 1231cc,剩余肝体积(FLR)为 25.1%(II 段和 III 段)。患者在手术间间隔期间于术后第 4 天出院;术后第 12 天 CT 扫描显示 FLR 增加至 33%(369cc)(图 1)。ALPPS 于术后第 17 天完成,术后过程无并发症,患者在二期手术后第 19 天一般情况良好出院。除了已经证明的降低手术间发病率的优势外,机器人 ALPPS 为 pCCA 患者扩大手术适应证提供了一种很有前途的策略。肝段分隔联合 PVE 可能会增加对有门静脉浸润的选定 pCCA 患者进行根治性切除的机会。